PMID: 6281811Feb 1, 1982Paper

Evidence for a mediator role of thromboxane A2 in the myotropic action of leukotriene B4 (LTB4) on the guinea-pig lung

Prostaglandins, Leukotrienes, and Medicine
P SiroisP Vallerand

Abstract

The mechanism of action of LTB4 has been investigated on the guinea-pig lung parenchymal strip. Mepacrine (20 microgram/ml), an inhibitor of phospholipase A2, abolished the action of LTB4 on parenchymal strips. Eicosatetraynoic acid (10 microgram/ml) and BW755C (40 microgram/ml) which are inhibitors of cyclooxygenase and lipoxygenase pathways, produced a marked inhibition of the lung strip contraction to LTB4. Similarly, aspirin (30 micrograms/ml) and flufenamate (1 microgram/ml) showed a strong inhibition of the contraction of parenchymal strips to LTB4; these results suggested that cyclooxygenase products mediate the action of LTB4. The response to LTB4 was unaffected by 15-hydroperoxyeicosatatraenoic acid (15-HPETE; 1 microgram/ml) while L8027 (25 ng/ml) reduced the contraction by 50%, suggesting that thromboxane A2 rather than prostacyclin was involved. Since parenchymal strips do not appear to be very sensitive to PGF2 alpha, PGE2 and the endoperoxides, and since effluents from LTB4-treated lungs produced contractions of lung strip and rabbit aorta which were reduced after 5 min. at 25 degrees, thromboxane A2 was postulated to mediate the lung effect of LTB4. The release of thromboxane B2 (TxB2) from lungs stimulated with ...Continue Reading

References

May 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P Borgeat, B Samuelsson
Jan 1, 1981·Thrombosis Research·J SpławińskiE Marcinkiewicz
Dec 1, 1980·Prostaglandins and Medicine·P SiroisG Girard
Feb 1, 1981·Prostaglandins and Medicine·P SiroisP Borgeat
Jan 1, 1980·International Journal of Immunopharmacology·P Sirois, P Borgeat
Feb 1, 1981·Journal of Medicinal Chemistry·P Borgeat, P Sirois

Citations

Aug 7, 1999·Clinical Reviews in Allergy & Immunology·S E Dahlén
Mar 1, 1983·Prostaglandins·R Hamel, A W Ford-Hutchinson
Nov 1, 1984·Prostaglandins, Leukotrienes, and Medicine·D R Bergren, D L Myers
Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·S E Dahlén
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·S CentanniA Sala
Jan 14, 2004·British Journal of Pharmacology·Kiyoto SakataMagnus Bäck
Jun 30, 1987·Biochemical and Biophysical Research Communications·W S Powell
Jun 1, 1994·American Journal of Surgery·S I Myers, R Hernandez
Oct 1, 1988·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S Prié, P Sirois
Jul 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T NagaseH Orimo
Jan 1, 1989·British Journal of Pharmacology·S JancarP Sirois
Mar 3, 2006·European Journal of Pharmacology·Sven-Erik Dahlén
Jun 15, 1983·Biochemical and Biophysical Research Communications·M Rola-PleszczynskiP Sirois
Apr 17, 1999·Journal of Internal Medicine·H E Claesson, S E Dahlén
Feb 1, 1983·Biochemical Pharmacology·P BorgeatJ Maclouf

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.